Courtney MonteparaAssistant Professor
School of Pharmacy
Division of Pharmacy Practice
213 Bayer Hall
Education:Pharm.D., Philadelphia College of Pharmacy, 2015
PGY1 Pharmacy Practice Residency, Atlantic Health System, 2016
PGY2 Cardiology Pharmacy Residency, Cleveland Clinic, 2017
Dr. Courtney Montepara received her Doctor of Pharmacy degree in 2015 from Philadelphia College of Pharmacy. She then completed a post-graduate pharmacy practice residency at Atlantic Health System in Morristown, New Jersey followed by a cardiology pharmacy specialty residency at Cleveland Clinic in Cleveland, Ohio. She also earned a teaching certificate through the Ernest Mario School of Pharmacy at Rutgers University in Piscataway, New Jersey.
Dr. Montepara is an Assistant Professor of Pharmacy Practice at Duquesne University School of Pharmacy and a cardiology pharmacy specialist at Allegheny General Hospital in Pittsburgh, Pennsylvania.
Montepara CA. Pharmacist-Led Atrial Fibrillation Screening Using Mobile Electrocardiogram Technology in the Ambulatory Care Setting. Pfizer Inc.
Role: Primary Investigator
Funds Awarded: $83,325
• $54,419 in October 2019
• $11,750 in June 2020
• $17,156 in November 2021
Montepara CA, Schoen RR, Horn PJ. Pandemic Precepting Pearls: Remote Delivery Strategies for APPE Learning. Pennsylvania Society of Health-System Pharmacists (PSHP) Emergency Preparedness Management Virtual Summit. September 2020.
Montepara CA, Stewart-Lynch A. Follow the Evidence: Applying the Pharmacists' Patient Care Process to Patients with Diabetes and Cardiovascular Disease. Duquesne University School of Pharmacy Annual Alumni Conference, Seven Springs, PA; September 2019.
Montepara CA, Stewart-Lynch A. Strategies to Improve Cardiovascular Outcomes: A Case-Based Approach to the Use of Novel Therapies in the Treatment of Diabetes. Pennsylvania Pharmacists Association (PPA) Annual Conference, Seven Springs, PA; September 2019.
Montepara CA, Faulkenberg KD, Greenlee KM, Bott-Silverman CE, Williams JB. Impact of an individualized education approach on readmission rates in heart failure patients. Ohio College of Clinical Pharmacy Fall Meeting, Cleveland, OH; November 2016.
Montepara CA, Bloomstein D, Serra M. Safety evaluation of the use of unfractionated heparin versus bivalirudin during percutaneous coronary intervention. 35th Eastern States Conference for Pharmacy Residents and Preceptors, Hershey, PA; May 2016.
Buck M, Haddon A, Paneccasio A, Skoloda D, Zimmerman DE, Guarascio AJ, Nemecek BD, Covvey JR, Montepara CA. The safety and efficacy of rivaroxaban and apixaban in patients with increased body weight: a systematic review. American College of Clinical Pharmacy Virtual Global Conference. October 2020.
Dusch AE, Horvath KM, Ruane MA, Sebastiani SE, Covvey JR, Zimmerman DE, Nemecek BD, Stanton B, Montepara CA. Clinical outcomes after switching between P2Y12 inhibitors post-acute coronary syndrome or percutaneous coronary intervention. American College of Clinical Pharmacy Global Conference, New York, NY; October 2019.
Montepara CA, Woods AG, Wolfgang KW. Problem-Based Learning (PBL): An educational strategy for the advancement of clinical pharmacy and team-based care in Italy. American College of Clinical Pharmacy Global Conference, New York, NY; October 2019.
Montepara CA, Wheeler ME, Lam SW, Faulkenberg KD, Williams JB. Dosing strategies of digoxin in acute decompensated heart failure requiring inotropic support. American College of Clinical Pharmacy Global Conference, Seattle, WA; October 2018.
Magda V, Calcagno T, Schreckengost B, Montepara CA, Covvey JR, Nemecek BD. As-needed intravenous labetalol and hydralazine use in hospitalized ward patients. American College of Clinical Pharmacy Global Conference, Seattle, WA; October 2018.
Montepara CA, Faulkenberg KD, Williams JB. Use of digoxin loading in acute decompensated heart failure. American College of Cardiology's 66th Annual Scientific Session & Expo, Washington, DC; March 2017.
Montepara CA, Faulkenberg KD, Greenlee KM, Bott-Silverman CE, Williams JB. Impact of an individualized education approach on readmission rates in heart failure patients.
• Ohio College of Clinical Pharmacy Spring Meeting, Cleveland, OH; May 2017.
• Vizient University HealthSystem Consortium Pharmacy Network Meeting, Las Vegas, NV; December 2016.
Montepara CA, Shah KJ, Hardeo SM. Evaluation of the appropriate use of stress ulcer prophylaxis during admission and upon discharge at a community teaching hospital.
• New Jersey Society of Health-System Pharmacists Annual Meeting and Exhibition, Long Branch, NJ; March 2016.
• 50th American Society of Health-System Pharmacists Midyear Clinical Meeting; New Orleans, LA; December 2015.
• University HealthSystem Consortium Pharmacy Network Meeting; New Orleans, LA; December 2015.
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease (FOURIER). American College of Clinical Pharmacy, Cardiology Practice and Research Network Journal Club; March 2017.
PHBM 432: Biomedical Sciences & Therapeutics: Cardiovascular Module
PHBM 401: Therapeutic Case Studies I: A Problem-Based Learning Approach
PHIN 423: Ability-Based Laboratory Experience III
PHPR 478: Seminar in Current Practice Guidelines in Ambulatory Care
PHPR 501: Pharmacy-Based Cardiovascular Disease Risk Management
Professor of the Year Award
• Class of 2023 – Weekday Pathway, AY 2020-2021
• Class of 2022 – Weekday Pathway, AY 2019-2020
• Class of 2022 – Weekend Pathway, AY 2019-2020
American College of Clinical Pharmacy Cardiology PRN Junior Investigator Award; November 2021
Order of Omega's Apple Polishing Award for Excellence in Faculty Performance; January 2020
First Place, Ohio College of Clinical Pharmacy Fall Meeting Research Presentation, Cleveland, OH; November 2016.